# Vistagen Therapeutics, Inc.: Form 8-K, filed Jun 15, 2026

- Company: [Vistagen Therapeutics, Inc.](/companies/vtgn.md) (CIK 1411685)
- Form: 8-K
- Filed: 2026-06-15
- Accepted by EDGAR: Jun 15, 2026, 16:35 ET
- Period: 2026-06-15
- Accession: 0001628280-26-043232
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1411685/000162828026043232/vtgn-20260615.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1411685/000162828026043232/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1411685/000162828026043232/vtgn-20260615.htm

Filed Jun 15, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-043232. Last ingested by Listed: Oct 30, 2026, 17:32 ET. No prices; not investment advice.